Clinical trial
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for…
NCT00381888 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00381888 |
|---|---|
| Title | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer |
| Official title | Women's Cancer Center Protocol #45: Prolonged Venous Thromboembolism Prophylaxis With Fondaparinux in Gynecologic Oncology Patients: An Open Label Phase II Trial |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma, Thromboembolism, Vaginal Cancer, Vulvar Cancer |
| Intervention type | Drug |
| Interventions | fondaparinux sodium |
| Enrollment | 44 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 28, 2006 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: